Product
Help
Pricing
About
Jobs
Log in
Get started
Author
Add to collection
Arseny D. Moralev
Observed names:
A.D. Moralev,
Arseny Moralev,
Moralev, Arseny D.
Institutions:
Institute of Chemical Biology and Fundamental Medicine,
Siberian Branch of the Russian Academy of Sciences
Observed institutions:
Novosibirsk State University,
Institute of Chemical Biology and Fundamental Medicine,
Siberian Branch of the Russian Academy of Sciences
ORCID:
0009-0001-0410-5403
Observed ORCID:
0009-0001-0410-5403
OpenAlex ID:
A5111091384
Novel Epoxides of Soloxolone Methyl: An Effect of the Formation of Oxirane Ring and Stereoisomerism on Cytotoxic Profile, Anti-Metastatic and Anti-Inflammatory Activities In Vitro and In Vivo
2022
·
Oksana V. Salomatina
, Aleksandra V. Sen’kova
, et al.
·
International Journal of Molecular Sciences
·
15
PDF
Sesquiterpene Lactones as Promising Anti-Glioblastoma Drug Candidates Exerting Complex Effects on Glioblastoma Cell Viability and Proneural–Mesenchymal Transition
2025
·
Andrey V. Markov
, Arseny D. Moralev
, et al.
·
Biomedicines
·
10
PDF
Synthesis and exploration of anticancer potential of spirocyclic 1,2,3-triazoline and aziridine derivatives of natural eudesmanolide isoalantolactone
2025
·
Sergey S. Patrushev
, Daria O. Kichkina
, et al.
·
Bioorganic Chemistry
·
10
A Novel 3-meta-Pyridine-1,2,4-oxadiazole Derivative of Glycyrrhetinic Acid as a Safe and Promising Candidate for Overcoming P-Glycoprotein-Mediated Multidrug Resistance in Tumor Cells
2023
·
Arseny D. Moralev
, Oksana V. Salomatina
, et al.
·
ACS Omega
·
9
PDF
Complex Inhibitory Activity of Pentacyclic Triterpenoids against Cutaneous Melanoma In Vitro and In Vivo: A Literature Review and Reconstruction of Their Melanoma-Related Protein Interactome
2024
·
Arseny D. Moralev
, Marina A. Zenkova
, et al.
·
ACS Pharmacology & Translational Science
·
8
PDF
Soloxolone N-3-(Dimethylamino)propylamide Restores Drug Sensitivity of Tumor Cells with Multidrug-Resistant Phenotype via Inhibition of P-Glycoprotein Efflux Function
2024
·
Arseny D. Moralev
, Oksana V. Salomatina
, et al.
·
Molecules
·
6
Novel Cross-Cancer Hub Genes in Doxorubicin Resistance Identified by Transcriptional Mapping
2025
·
Arseny D. Moralev
, Oleg V. Markov
, et al.
·
Biomedicines
·
5
Soloxolone N-3-(Dimethylamino)propylamide Suppresses Tumor Growth and Mitigates Doxorubicin-Induced Hepatotoxicity in RLS40 Lymphosarcoma-Bearing Mice
2025
·
Arseny D. Moralev
, Aleksandra V. Sen’kova
, et al.
·
International Journal of Molecular Sciences
·
2
PDF
Reversing the Irreversible: miRNA-Targeting Mesyl Phosphoramidate Oligonucleotides Restore Sensitivity to Cisplatin and Doxorubicin of KB-8-5 Epidermoid Carcinoma Cells
2025
·
Svetlana Miroshnichenko
, Rabia Demirel
, et al.
·
Biomedicines
·
1
PDF
N-(3’-(Dimethylamino)propyl)amides based on 18βH-glycyrrhetinic acid retain P-glycoprotein inhibitory and MDR-reversing activities
2026
·
Arseny D. Moralev
, Nika V. Konoreva
, et al.
·
Biochemical and Biophysical Research Communications
New Marker Genes of Tumor Cell Resistance to Doxorubicin and the Development of Drug Candidates for Its Therapy
2023
·
A.D. Moralev
, O.V. Salomatina
, et al.
·
Международная конференция молодых ученых: биоинформатиков, биотехнологов, биофизиков, вирусологов и молекулярных биологов (OpenBio)
New Semisynthetic Sesquiterpene Lactones as Inducers of Oxidative Stress in Tumor Cells and Blockers of the Aggressive Phenotype of Glioblastoma Multiforme Cells
2023
·
D.O. Kichkina
, S.S. Patrushev
, et al.
·
Международная конференция молодых ученых: биоинформатиков, биотехнологов, биофизиков, вирусологов и молекулярных биологов (OpenBio)
Show more works
View as search
Works count:
20
Citation count:
66
H-index:
6
I10-index:
3
Year
Topic
Type